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Abstract
Background: Limb development and patterning originate from a complex interplay between the
skeletal elements, tendons, and muscles of the limb. One of the genes involved in patterning of limb
muscles is the homeobox transcription factor Pitx2  but its role in forelimb development is
uncharacterized. Pitx2 is expressed in the majority of premature presumptive forelimb musculature
at embryonic day 12.5 and then maintained throughout embryogenesis to adult skeletal muscle.
Results: To further study the role of Pitx2 in forelimb development we have generated transgenic
mice that exhibit a pulse of PITX2 over-expression at embryonic day 13.5 and 14.5 in the
developing forelimb mesenchyme. These mice exhibit a distal misplacement of the biceps brachii
insertion during embryogenesis, which twists the forelimb musculature resulting in severe skeletal
malformations. The skeletal malformations have some similarities to the forearm deformities
present in Leri-Weill dyschondrosteosis.
Conclusion: Taken together, the tendon, muscle, and bone anomalies further support a role of
Pitx2 in forelimb development and may also shed light on the interaction between the skeletal
elements and muscles of the limb during embryogenesis.
Background
Limb development and patterning originate from close
interactions between tendon, cartilage and muscle precur-
sor cells. Mouse forelimb development is first evident at
about embryonic day (E) 9.5. Approximately 24 h later
myogenic cells are identified at the base of the forelimb
and at E11.5 the first hint of humerus is apparent [1]. At
E14.5 a miniature model of the forelimb has been
formed. Limb muscle precursors migrate from the lateral
part of the somites into the limb bud where they undergo
final differentiation. Among the transcription factors
involved in early myogenesis are Pax3 and Lbx1 whose
expression precedes the expression of myogenic regula-
tory factors (MRFs). MRFs belong to the MyoD family of
basic helix-loop-helix factors. In mammals there are four
such factors: Myf5, MyoD, myogenin, and MRF4 [2]. Little
is known about the mechanisms whereby these genes reg-
ulate limb muscle development. The homeobox transcrip-
tion factor PITX2 was originally identified as one of the
genes responsible for Axenfeld-Rieger syndrome, mainly
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affecting eyes, teeth, and abdominal organs [3,4]. Pitx2 is
expressed in a subset of Pax3+ limb muscle precursors
already at E10.5. By E12.5 Pitx2 is expressed in all limb
musculature and persists until adulthood [5]. Still, Pitx2
null mutants form nearly all muscle anlagen even though
several of these muscle anlagen are distorted, coupled
with malformation of the part of the body to which they
attach [6]. Muscles attach to bone through tendons. Limb
tendon cells originate from lateral plate mesoderm and
tendon progenitor cells are regionalized in the dorsal and
ventral areas of the limb where they are mixed with mus-
cle progenitor cells [7,8]. Compared to other mesodermal
tissues, such as blood vessels, cartilage, bone, and mus-
cles, very little is known about the early formation and
role of tendons during development. Among the tran-
scription factors identified in developing tendons are scle-
raxis, Eya1, Eya2, Six1, and Six2 of which Eya1, Eya2, Six1
and Six2  are also expressed in limb muscle precursors
[7,9-11]. This parallel expression in myoblast precursors
of somite origin and in mesenchymal cells derived from
the lateral plate may ensure correct and concerted migra-
tion of the two cell types [12]. To further study the role of
Pitx2 in forelimb development we have generated mice
that exhibit a brief pulse of PITX2 over-expression in the
forelimb mesenchyme from E13.5 to E14.5. The expres-
sion is driven by mouse keratocan (Kera) 5'-flanking
sequence, which has been used previously to achieve over-
expression of PITX2 in the cornea [13]. The construct was
termed Ktcn-PITX2. Keratocan is one of three major com-
ponents of the extracellular keratan sulfate proteoglycans
present mainly in vertebrate corneal stroma but also
expressed in non-ocular tissues such as skeletal muscle
and tendon [14,15]. The Kera gene is expressed in limbs of
mouse embryos at E13.5 and E14.5 [16,17]. This is the
first report of PITX2 over-expression in the forelimb. The
Ktcn-PITX2 mice exhibit PITX2 over-expression in the
anterior forelimb mesenchyme extending from the
humerus to the radius. The cells over-expressing PITX2 are
of non-myogenic origin and co-express Six2. As Six2 is
involved in tendon development, we hypothesize that the
observed expression disturbs correct muscle insertion,
which in the Ktcn-PITX2 mouse leads to a random left-
right distal misplacement of the biceps brachii insertion.
This in turn results in a 180 degrees twist of the forelimb
musculature. The muscle and tendon anomalies also lead
to severe skeletal malformations consisting of a short-
ened, thickened and malformed humerus, a bowed ulna
and a deformed radius. These skeletal malformations have
some similarities to the pathogenesis of Leri-Weill
dyschondrosteosis, which is characterized by dispropor-
tionate short stature and a characteristic curving of the
radius, known as the Madelung deformity [18]. In conclu-
sion, these findings may increase our understanding
about the role of Pitx2 in limb development and on the
interactions between muscle, tendon, and bone during
development.
Results
Ktcn-PITX2 mice have shortened, thickened and 
malformed humerus, deformed radius and bowed ulna
The Ktcn-PITX2 forelimb phenotype occurs randomly on
either left or right forelimb. Occasionally both forelimbs
are affected (Table 1). The bone malformations consist of
a shortened, thickened and malformed humerus and a
diminished deltoid tuberosity. The humerus malforma-
tion is most prominent distally and partly distorts the ole-
cranon fossa. The olecranon fossa is a dorsal depression
that receives the olecranon (elbow) of the ulna when the
forearm is extended. This leads to a slight dislocation of
the proximal ulna. Radius is bent proximally and
approaches the elbow joint from a straight angel (Figure
1A). This locks the elbow in a simultaneous pronation-
extension and forces the ulna to bend upwards to reach
the carpals. The limitations in elbow movement in com-
bination with the 180 degrees twist of the paw makes the
forelimb insufficient to support on (Figure 1B). Hind-
limbs, in contrast, do not exhibit any phenotype. The
Ktcn-PITX2 mice are fertile and have normal life span.
Limb malformations are present in E18.5 and in newborn 
Ktcn-PITX2 mice
To investigate potential embryonic bone and cartilage
anomalies we stained forelimbs from E18.5 and newborn
mice with Alcian Blue and Alizarin Red. At E18.5 Ktcn-
PITX2 mice display a diminished deltoid tuberosity and
newborn Ktcn-PITX2 mice also exhibit a distal thickening
of the humerus. The thickening tends to partly dislocate
the radius anteriorly and also slightly dislocate the proxi-
mal part of the ulna in a more lateral-dorsal position,
which makes the ulna appear twisted (Figure 2). Bone and
cartilage zones were carefully examined at high resolution
but appeared normal in the Ktcn-PITX2 forelimbs of all
ages (data not shown).
Ktcn-PITX2 mice over-express PITX2 in the forelimbs
The Ktcn-PITX2 mouse model was originally made to
study the function of the homeobox gene PITX2A in eye
development and its role in the pathology of Axenfeld-
Rieger syndrome and glaucoma [13]. The Ktcn-PITX2
mice over-express human PITX2A in the cornea and iris
under the Kera  promoter and upstream regulatory ele-
ments, but Kera is also expressed throughout the limbs of
embryos from E13.5 to E14.5 [17]. To study whether the
Ktcn-PITX2 mice express human PITX2 mRNA in the fore-
limbs at the same embryonic stages as Kera is expressed we
isolated forelimb RNA from Ktcn-PITX2 embryos (E12.5,
E13.5, E14.5, and E15.5) and performed semi-quantita-
tive RT-PCR. Human PITX2A  mRNA expression level
peaked at E13.5 and E14.5 and declined thereafter, con-BMC Developmental Biology 2008, 8:25 http://www.biomedcentral.com/1471-213X/8/25
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sistent with the expression pattern of Kera (Figure 3). Fur-
ther, we used immunohistochemistry to study the
expression pattern of PITX2 protein in the forelimbs at
E13.5. In wild type embryos Pitx2 expression is restricted
to well defined anterior and posterior muscle groups con-
sistent with previous observations (Figure 4C,E,G) [5]. In
the Ktcn-PITX2 forelimbs we observed a proximal anterior
over-expression of PITX2 in the mesenchyme close to the
humerus but also an anterior over-expression in the mes-
enchyme expanding from the elbow joint to the distal part
of radius. These areas did not stain for muscle specific
antibodies against Pax3, MyoD1, myogenin, or myosin
(Figure 4D,F,H and data not shown). This could either be
due to that the cells over-expressing PITX2 are not of myo-
genic origin, or muscle markers are down regulated as a
result of the over-expression. In vitro studies have shown
that Pitx2C over-expression promotes cell proliferation
and arrests differentiation in myoblasts [19]. However, in
the forelimbs of adult Ktcn-PITX2 mice, all muscle groups
are present, indicating that the cells over-expressing PITX2
Forelimbs of Ktcn-PITX2 mice exhibit severe bone malfor- mations Figure 1
Forelimbs of Ktcn-PITX2 mice exhibit severe bone 
malformations. (A) X-ray images and Alizarin Red staining 
of wild type (left panel) and Ktcn-PITX2 (right panel) adult 
forelimbs. Right panel: Alizarin Red staining of Ktcn-PITX2 
forelimb (ventral view) shows a diminished and misplaced 
deltoid tuberosity. The humerus and radius are malformed. 
Note the proximal bend of the radius, which results in a pos-
terior misplacement. (B) A Ktcn-PITX2 mouse displays the 
characteristic forelimb phenotype. Abbreviations: dt, deltoid 
tuberosity; h, humerus; r, radius; u, ulna.
A
B
wt Ktcn-PITX2
h h
dt
u
r
r
Table 1: Distribution of phenotypes in 1-month-old wild type and 
Ktcn-PITX2 mice.
Normal Mild (left/right/both) Severe (left/right/both) Total
Wild type
15 0 0 15
Ktcn-PITX2
10 30 (15/12/3) 36 (14/15/7) 76
Skeletal malformations are present in E18.5 and in newborn  Ktcn-PITX2 mice Figure 2
Skeletal malformations are present in E18.5 and in 
newborn Ktcn-PITX2 mice. Alizarin Red and Alcian Blue 
stainings of forelimbs from E18.5 (upper section) and new-
born (lower section) mice. Forelimbs of E18.5 and newborn 
Ktcn-PITX2 mice display a diminished deltoid tuberosity (*). 
Newborn Ktcn-PITX2 mice also exhibit a thickening of the 
distal humerus, which tends to partly dislocate the radius 
anteriorly and also slightly dislocate the proximal part of the 
ulna in a more lateral-dorsal position, which makes the ulna 
appear twisted (arrows).
Ktcn-
PITX2
Ktcn-
PITX2
wt
wt
E18.5
newborn
*
*
Expression of human PITX2 mRNA in forelimbs of Ktcn- PITX2 mice Figure 3
Expression of human PITX2 mRNA in forelimbs of 
Ktcn-PITX2 mice. Semi-quantitative RT-PCR of E12.5, 
E13.5, E14.5, and E15.5 Ktcn-PITX2 mouse forelimbs shows 
a PITX2 expression peak at E13.5-14.5.
PITX2
Rps18
cycles
E12.5 E13.5 E14.5 E15.5
22 22 22 22 24 24 24 24 26 26 26 26BMC Developmental Biology 2008, 8:25 http://www.biomedcentral.com/1471-213X/8/25
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are of non-myogenic origin. In the Ktcn-PITX2 mice, we
consistently observed PITX2 over-expression in both right
and left forelimbs (Figure 5C,D). It has been reported that
Pitx2 regulates the expression of cyclin D2 (Ccnd2) after
Wnt induction in C2C12 myoblasts [20]. We did not
detect any increased expression of Ccnd2 in the cells over-
expressing PITX2 or any increased apoptotic activity (Fig-
ure 6). Notably, the region of over-expression is situated
close to where the first phenotypes later appear.
The biceps brachii of Ktcn-PITX2 mice has a misplaced 
insertion
To gain a deeper understanding of the forelimb pheno-
type we dissected forelimbs from adult Ktcn-PITX2 mice.
Despite the obvious twist of the musculature, all muscle
groups are present and originate and insert correctly
except for biceps brachii. Biceps brachii is a flexor muscle
whose function is to decrease the joint angle at the elbow
but also to supinate (turn palm superiorly or anteriorly)
the forearm at the radioulnar joints. It originates at two
separate sites in the scapula and inserts at the proximal
part of the radius. In the Ktcn-PITX2 mice biceps brachii
insertion is altered as its distal tendon is curled around the
radius and inserts dorsally at the very most distal part of
the bone (Figure 7). This would explain the limited elbow
motion but also the permanent pronation of the Ktcn-
PITX2 forelimbs. Muscle groups work as antagonists. If
the supination movement is impaired its antagonist, the
pronator, will dominate, which may result in the prona-
tion position.
PITX2 and Six2 are co-expressed in non-myogenic cells in 
the Ktcn-PITX2 forelimbs
To study the molecular mechanism behind the Ktcn-
PITX2 forelimb tendon anomalies and to further charac-
terize the identity of the cells over-expressing PITX2, we
analyzed the expression of Six2 in wild type and Ktcn-
PITX2 forelimbs. At E13.5 both Pitx2 and Six2 are
expressed in the developing forelimb musculature (Figure
8C,E), but in the Ktcn-PITX2 embryos, Six2 is also
expressed in a limited area within the non-myogenic cells
over-expressing PITX2 (Figure 8D,F). This co-expression is
more evident 24 h later. At E14.5 Six2 expression overlaps
a substantial area of the cells over-expressing PITX2 (Fig-
PITX2 is over-expressed in non-myogenic cells Figure 4
PITX2 is over-expressed in non-myogenic cells. (A 
and B) H&E stained sagittal paraffin sections of E13.5 wild 
type and Ktcn-PITX2 forelimbs. (C, E, G) Pitx2 is expressed 
in the musculature of wild type forelimbs (arrowheads) as 
evident from its co-expression with myosin. (D, F, H) PITX2 
is over-expressed in the anterior mesenchyme reaching from 
the humerus to the distal part of radius (arrows). Note that 
the cells over-expressing PITX2 do not stain for muscle spe-
cific antibodies. Scale bar: 1 mm.
H&E
PITX2
myosin
PITX2/
myosin
wt Ktcn-PITX2
AB
C D
EF
GH
PITX2 is over-expressed in both right and left forelimbs of  the Ktcn-PITX2 mice Figure 5
PITX2 is over-expressed in both right and left fore-
limbs of the Ktcn-PITX2 mice. (A and B) H&E stained 
sagittal paraffin sections of left and right forelimb from one 
individual E14.5 mouse. The marked areas are magnified in C 
and D. (C and D) Immunohistochemistry reveals PITX2 
over-expression in both right and left forelimb. Scale bar: 0.5 
mm.
PITX2
left right
A B
H&E
CDBMC Developmental Biology 2008, 8:25 http://www.biomedcentral.com/1471-213X/8/25
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ure 9C–F). This suggests a relationship between Pitx2 and
Six2 and indicates that at least part of the cells over-
expressing PITX2 are involved in tendinous patterning. In
addition, studies performed in silico show several poten-
tial Bicoid/Pitx2 binding sites in the Six2 promoter (data
not shown).
Discussion
Pitx2 acts in hindlimb development together with Pitx1
where the former specifies laterality and the latter deter-
mines hindlimb identity [21]. During forelimb develop-
ment Pitx2 is expressed in almost all muscle anlagen from
embryogenesis until adulthood [4,5,22-24]. We show
here for the first time that over-expression of PITX2 in
non-myogenic cells of the developing forelimb results in
a distal misplacement of the biceps brachii insertion,
which gives rise to severe bone malformations, randomly
affecting left or right forelimb. The bone anomalies
include a diminished deltoid tuberosity, a shortened,
thickened and malformed humerus. In addition, it causes
the radius to approach the elbow via a perpendicular
bend, which in turn limits the elbow movement, and
forces a dorsally dislocated ulna to curve over radius to
reach the carpals. The phenotype worsens two to three
weeks after birth, possibly due to the increased load on
the forelimbs as the mouse starts to walk. On the other
hand we frequently detected mice with both forelimbs
affected from early on. Also, mice with only one affected
leg never developed any phenotype on the supporting leg.
The skeletal malformations have some similarities to the
Unchanged expression of Ccnd2 and no differences in apop- totic activity in the Ktcn-PITX2 forelimbs Figure 6
Unchanged expression of Ccnd2 and no differences in 
apoptotic activity in the Ktcn-PITX2 forelimbs. (A and 
B) H&E stained sagittal paraffin sections of forelimbs from 
E14.5 mice. The marked areas in A and B are magnified in C-
H. (C-F) Double labeling immunohistochemistry reveals that 
the cells over-expressing PITX2 (D) do not display an 
increased expression of Ccnd2 (F). (G and H) TUNEL stain-
ing of sections from wild type and Ktcn-PITX2 forelimbs 
does not show any difference in apoptotic activity in the cells 
over-expressing PITX2. Scale bar: 0.5 mm.
H&E
PITX2
Ccnd2
TUNEL
wt Ktcn-PITX2
AB
CD
EF
GH
Forelimbs of adult Ktcn-PITX2 mice display tendon anoma- lies Figure 7
Forelimbs of adult Ktcn-PITX2 mice display tendon 
anomalies. (A and B) The adult Ktcn-PITX2 limb muscula-
ture is twisted 180 degrees compared to wild type. Still, all 
muscle groups are present. (C) Normally, biceps brachii 
inserts at the proximal part of the radius (white arrow). (D) 
In the Ktcn-PITX2 mice biceps brachii insertion is altered 
(white arrow) as its distal end is curled around the radius 
(black arrow) and inserts dorsally at the very most distal part 
of the bone.
Ktcn-
PITX2
lateral
wt
ventral
wt Ktcn-PITX2
AB
C
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pathogenesis of Leri-Weill dyschondrosteosis, character-
ized by disproportionate short stature, curving of the
radius, and subluxation of the distal end of the ulna.
Mutations in the SHOX gene have been shown to cause
the disorder. However, for 27% of the cases, no causative
gene has been identified [25]. Pitx2 is expressed in the left
lateral plate mesoderm and acts as an effector for left-right
asymmetry in mesoderm derived organs such as lungs
[26]. Also, Pitx1-/- embryos show left-right asymmetry in
the severity of a hindlimb phenotype due to redundancy
between Pitx1 and Pitx2 [21]. Still, the limbs are symmet-
rical. It has previously been shown that function of Pitx2
is dosage-sensitive [13,27,28]. Hence, the more plausible
explanation for the random left-right forelimb anomalies
of the Ktcn-PITX2 mice could be minor differences in
PITX2 expression levels between left and right. Pitx2
expression in limbs is restricted to muscle lineages and it
has recently been shown that Pitx2 is one of the most
complete muscle markers [5]. Immunohistochemistry on
wild type forelimb sections demonstrate co-expression of
Pitx2 and other muscle markers such as MyoD, myogenin,
and myosin. In contrast, the cells over-expressing PITX2 in
the Ktcn-PITX2 forelimbs do not express any of these mus-
cle markers. Based on the observed tendon anomalies in
the Ktcn-PITX2 forelimbs we stained for Six2, normally
expressed in developing tendons. Co-expression of PITX2
and Six2 could indicate that the cells over-expressing
PITX2 are involved in tendon development and position-
ing. The factors regulating correct attachments of tendons
to bone and the time of commitment of tendon precur-
sors to a tendon cell fate in vertebrates are largely
unknown [29]. However, reports have shown that myo-
tubes can induce tendon primordial into individual ten-
dons and, moreover, if tendon precursors are removed,
myotubes attach ectopically [30]. It is possible that the
observed expression of Six2 in the cells over-expressing
PITX2 interferes with the signals coordinating correct ten-
don insertion. Based on the observed co-expression of
At E13.5 PITX2 and Six2 are co-expressed in a limited num- bers of non-myogenic cells Figure 8
At E13.5 PITX2 and Six2 are co-expressed in a lim-
ited numbers of non-myogenic cells. (A and B) H&E 
stained sagittal sections of E13.5 wild type and Ktcn-PITX2 
forelimbs. (C-H) At E13.5 both Pitx2 and Six2 are expressed 
in the developing forelimb musculature (*). (D, F) In the 
Ktcn-PITX2 forelimb, Six2 is also expressed in a limited num-
bers of the non-myogenic cells over-expressing PITX2 
(arrow). Scale bar: 1 mm.
H&E
wt Ktcn-PITX2
AB
myosin *
GH
Six2
*
EF
PITX2
*
CD
At E14.5 PITX2 and Six2 are fully co-expressed in non-myo- genic cells Figure 9
At E14.5 PITX2 and Six2 are fully co-expressed in 
non-myogenic cells. (A) H&E stained sagittal section of 
E14.5 Ktcn-PITX2 forelimb. The marked area is magnified in 
B-D. (B-D) At E14.5 Six2 expression overlaps a substantial 
area of the non-myogenic cells over-expressing PITX2. The 
marked areas are further magnified in E-F and overlaid in F'. 
Scale bar: 0.5 mm.
PITX2
X20
H&E myosin
PITX2 Six2
Six2
X20
A B
CD
EF
Ktcn-PITX2
F’BMC Developmental Biology 2008, 8:25 http://www.biomedcentral.com/1471-213X/8/25
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PITX2 and Six2 in our mouse model it is intriguing to note
that both transcription factors are expressed during other
developmental processes. Neural crest cells that migrate to
the periocular mesenchyme during eye development
express both Pitx2 and Six2 [31,32]. In addition, Eya1,
another limb tendon marker, is expressed in developing
anterior chamber structures of the eye including the iris,
ciliary structures, and cornea, tissues that also express
Pitx2 [12]. It would be interesting to further study a possi-
ble relation between Pitx2, Six2, and Eya1. Notably, Pitx1
is closely related to Pitx2 and normally involved in and
restricted to hindlimb development. When ectopically
expressed in the forelimbs it induces transformation and
translocation of specific muscles, tendons, and bones of
the forelimb [33]. Finally, the temporal overlap of muscle
and tendon formation with the over-expression of PITX2
makes the Ktcn-PITX2 mouse an appropriate animal
model to study the development of the musculoskeletal
system.
Conclusion
Over-expression of PITX2 during mouse forelimb devel-
opment results in severe tendon, muscle, and bone anom-
alies. These observations further support a role of Pitx2 in
forelimb development. This animal model may also be
valuable for future studies on the interaction between the
skeletal elements and muscles of the limb during embry-
ogenesis and it could provide information on new regula-
tory pathways involving PITX2.
Methods
Mice
Transgenic animals were previously described [13]. The
local ethics committee for animal research has approved
of our experiments (Lund district). The mice were housed
and treated according to guidelines of national and local
animal ethics guidelines at the BMC animal facilities at
Lund University, Lund.
RNA isolation and RT-PCR
We used Trizol (InVitrogen, Carlsbad, CA) and RNeasy
MinElute Clean-up (Qiagen, Valencia, CA) kits to isolate
total RNA from limbs. Tissues were whole forelimbs fro-
zen in liquid nitrogen, grinded on dry ice, and further
homogenized in Trizol with syringes. RNA was purified
with phenol/chloroform, precipitated, and treated with
DNA-free (Ambion, Austin, TX) to remove contaminating
DNA. Reverse transcription was performed using Super-
scriptII (Gibco/BRL/InVitrogen, Carlsbad, CA). We used a
mixture of random hexamer and oligo-dT primers
(Promega, Madison, WI) according to the recommenda-
tions of the manufacturer. We used an amplicon for ribos-
omal binding protein 18 (Rps18) as a loading control.
PITX2A and Rps18 were amplified as described [13].
Histological techniques
Limbs were fixed in 4% formaldehyde in PBS and then
embedded in paraffin according to standard procedures.
Sections of 5 μm were mounted on slides. Sections for
immunohistochemistry were deparaffinized and boiled in
0.1 M sodium citrate and 0.05% Tween 20 for 15 minutes
prior to over night primary antibody staining. Antibodies
were against PITX2A [32], cyclin D2 (Abcam, Cambridge,
UK), myosin (My32), MyoD1 (SIGMA, Saint Louis, MO),
Pax3, myogenin (F5D) (Developmental Studies Hybrid-
oma Bank, Iowa City, IA), and Six2 (Affinity Bioreagents,
Golden, CO). We used goat anti-rabbit Alexafluor 546,
goat anti-mouse 488, and rabbit-anti-goat Alexafluor 546
as secondary antibodies (Molecular Probes, Eugene, OR).
Slides were mounted in Permafluor (Beckman-Coulter,
Fullerton, CA).
Terminal dUTP nick-end labeling (TUNEL) assay
We used the In situ cell death detection kit fluorescein
(Roche, Indianapolis, IN), to test apoptotic activity on 5
μm paraffin sections according to the recommendations
of the manufacturer. Slides were mounted in Permafluor
(Beckman-Coulter) and viewed in a fluorescence micro-
scope.
Bone and cartilage staining
Embryos and newborn animals were skinned, eviscerated
and fixed in 95% ethanol for one week. The specimens
were then placed in acetone for one week, stained in 1 vol-
ume 0,1% filtered alizarin red S (SIGMA), 1 volume 0,3%
filtered alcian blue 8GX (SIGMA), 1 volume 99.8% acetic
acid, and 17 volumes 70% ethanol for one week, cleared
in 1% KOH, destained in 20% glycerol + 1% KOH, and
transferred through a graded glycerol series and stored in
100% glycerol.
X-ray imaging
The mice were sacrificed before X-ray exposure. A clinical
Arco Ceil, Arcoma, Generator CPI Indico 100, and Canon
CXDI-31 Portable DR System were used. Exposure settings
were: 46 kV, 1.6 mAs.
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